MycoMedica
Shelton, US · 2 known investors
MycoMedica Life Sciences is a biopharmaceutical company developing psilocybin-based treatments for mental health and neurodegenerative disorders. It conducts non-clinical and human clinical studies of low-dose psilocybin, with an initial focus on Premenstrual Dysphoric Disorder and other neuropsychiatric conditions such as OCD, Opioid Use Disorder, and Parkinson's Disease.
Investors · 2
Competitors · 2
by search overlapCreate3 shared keywordsCREATE Medicines is a clinical-stage biotech company that develops in vivo mRNA immune cell programming therapies. The company focuses on RNA therapeutics and immune engineering for cancer, autoimmune disease, and transplant rejection applications.
Medscape3 shared keywordsMedscape is an online medical information platform providing clinical news, expert perspectives, case studies, quizzes, and reference material across specialties such as cardiology, oncology, neurology, and psychiatry. It serves physicians, nurses, pharmacists, residents, and medical students.
Companies competing with MycoMedica for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does MycoMedica do?
- MycoMedica Life Sciences is a biopharmaceutical company developing psilocybin-based treatments for mental health and neurodegenerative disorders. It conducts non-clinical and human clinical studies of low-dose psilocybin, with an initial focus on Premenstrual Dysphoric Disorder and other neuropsychiatric conditions such as OCD, Opioid Use Disorder, and Parkinson's Disease.
- Who are MycoMedica's investors?
- MycoMedica's investors include Lauder Partners, Obvious Ventures.
- Where is MycoMedica headquartered?
- MycoMedica is headquartered in Shelton, US.